APA (7th ed.) Citation

Robert Dobbins, Elizabeth K. Hussey, Robin O'Connor-Semmes, Susan Andrews, Wenli Tao, William O. Wilkison, . . . Barkate Hanmant. (2021). Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin. BMC.

Chicago Style (17th ed.) Citation

Robert Dobbins, Elizabeth K. Hussey, Robin O'Connor-Semmes, Susan Andrews, Wenli Tao, William O. Wilkison, Bentley Cheatham, Katare Sagar, and Barkate Hanmant. Assessment of Safety and Tolerability of Remogliflozin Etabonate (GSK189075) When Administered with Total Daily Dose of 2000 Mg of Metformin. BMC, 2021.

MLA (9th ed.) Citation

Robert Dobbins, et al. Assessment of Safety and Tolerability of Remogliflozin Etabonate (GSK189075) When Administered with Total Daily Dose of 2000 Mg of Metformin. BMC, 2021.